TENX
No price yet
Announcements
Nothing here yet
Daily updates
FDA designations
Nothing here yet
News
- Tenax Therapeutics announced topline Phase 3 LEVEL results for TNX-103 in patients with pulmonary hypertension associated with heart failure with preserved ejection fractionAug 10, 2026
- Tenax Therapeutics announces European Patent Office intention to grant patent covering use of Levosimendan in PH-HFpEFSep 16, 2025